+高级检索
UV/PS工艺降解水中环丙沙星的产物及机理分析
DOI:
作者:
作者单位:

作者简介:

通讯作者:

基金项目:


Products and Mechanism Analysis of Ciprofloxacin Degradation inWater by UV activated Persulfate
Author:
Affiliation:

Fund Project:

  • 摘要
  • |
  • 图/表
  • |
  • 访问统计
  • |
  • 参考文献
  • |
  • 相似文献
  • |
  • 引证文献
  • |
  • 资源附件
    摘要:

    水环境中残留的氟喹诺酮抗生素(FQs)所造成的长期生态及生理毒性已引起了人们的广泛关注.本文采用基于紫外光活化过硫酸盐的新型高级氧化工艺氧化降解水中典型氟喹诺酮抗生素环丙沙星(CIP),对其降解产物进行定性与定量表征,并通过量子化学分析与质谱检测结果提出UV/过硫酸盐工艺降解环丙沙星的详细降解路径.结果表明,该工艺降解CIP最佳pH为9.0,30 min反应后,溶液体系中检测出包括醇类、酚类、酰胺类及酮类等在内13种中间产物,且部分中间产物浓度呈现先升高后降低的趋势.氧化反应主要集中在喹诺酮核心的C-F键、羧酸基团及哌嗪基团上.UV/PS工艺降解环丙沙星的降解包含四个主要路径,通过一系列的脱氟、光裂解、取代、加成及脱氨基反应,最终导致目标物开环裂解.

    Abstract:

    Long term ecological and physiological toxicity caused by the residuals of fluoroquinolones (FQs) in the aquatic environment has raised much attention. Ciprofloxacin as a typical FQs was degraded by UV activated persulfate,which was a new advanced oxidation technology. The degradation products were characterized using qualitative and quantitative methods,and the detailed degradation mechanism and pathways of ciprofloxacin by UV/persulfate were proposed by using the analysis results of quantum chemistry and mass spectra. The results revealed that the optima condition for CIP degradation was pH 9.0. After a 30 min reaction,13 intermediates were identified in the solutions,including alcohols,phenols,ketones and amides. The concentrations of several intermediates exhibited an up and down trend. Oxidations mainly occurred at the C F bond and carboxylic acid on quinolone group,as well as piperazine group. The degradation of CIP by UV/PS mainly included four pathways,and a series of defluorination,photolysis,substitution,addition and deamination were observed,leading to the final open ring reaction of target compound.

    参考文献
    相似文献
    引证文献
文章指标
  • PDF下载次数:
  • HTML阅读次数:
  • 摘要点击次数:
  • 引用次数:
引用本文

郭洪光,刘杨,柯亭伶,赵程伟 ,唐炜鸿. UV/PS工艺降解水中环丙沙星的产物及机理分析[J].湖南大学学报:自然科学版,2017,44(6):150~156

复制
历史
  • 收稿日期:
  • 最后修改日期:
  • 录用日期:
  • 在线发布日期: 2017-07-07
  • 出版日期:
作者稿件一经被我刊录用,如无特别声明,即视作同意授予我刊论文整体的全部复制传播的权利,包括但不限于复制权、发行权、信息网络传播权、广播权、表演权、翻译权、汇编权、改编权等著作使用权转让给我刊,我刊有权根据工作需要,允许合作的数据库、新媒体平台及其他数字平台进行数字传播和国际传播等。特此声明。
关闭